Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukins Inhibitors, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Product Type (Biologics and Non-Biologics), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI100600

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Psoriasis, By Key Countries, 2025
2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
3. New Product Launches, By Key Players
4. Pipeline Analysis, By Key Players
5. Key Industry Developments, By Key Players
6. Impact of COVID-19 on the Market
Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K
    1. By Type
  2. Germany
    1. By Type
  3. France
    1. By Type
  4. Spain
    1. By Type
  5. Italy
    1. By Type
  6. Scandinavia
    1. By Type
  7. Rest of Europe
    1. By Type
Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Type
  2. China
    1. By Type
  3. India
    1. By Type
  4. Australia & New Zealand
    1. By Type
  5. Rest of Asia Pacific
    1. By Type
Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Type
  2. Mexico
    1. By Type
  3. Rest of Latin America
    1. By Type
Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Type
  2. South Africa
    1. By Type
  3. Rest of Middle East & Africa
    1. By Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Novartis AG
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. LEO Pharma A/S
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Merck & Co., Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Amgen Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Eli Lilly and Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Evelo Biosciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. UCB S.A.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Sun Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Psoriasis, By Key Countries, 2025
2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
3. New Product Launches, By Key Players
4. Pipeline Analysis, By Key Players
5. Key Industry Developments, By Key Players
6. Impact of COVID-19 on the Market
Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Type
  2. Canada
    1. By Type
Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K
    1. By Type
  2. Germany
    1. By Type
  3. France
    1. By Type
  4. Spain
    1. By Type
  5. Italy
    1. By Type
  6. Scandinavia
    1. By Type
  7. Rest of Europe
    1. By Type
Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Type
  2. China
    1. By Type
  3. India
    1. By Type
  4. Australia & New Zealand
    1. By Type
  5. Rest of Asia Pacific
    1. By Type
Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Type
  2. Mexico
    1. By Type
  3. Rest of Latin America
    1. By Type
Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug Class
  1. TNF Inhibitors
  2. Interleukins Inhibitors
  3. Others
2. Market Analysis, Insights and Forecast – By Type
  1. Plaque Psoriasis
  2. Psoriatic Arthritis
  3. Others
3. Market Analysis, Insights and Forecast – By Product Type
  1. Biologics
  2. Non-Biologics
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral/Systemic
  3. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Type
  2. South Africa
    1. By Type
  3. Rest of Middle East & Africa
    1. By Type
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Novartis AG
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Johnson & Johnson Services, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Pfizer Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. LEO Pharma A/S
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Merck & Co., Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Amgen Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Eli Lilly and Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Evelo Biosciences, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. UCB S.A.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Sun Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Psoriasis Treatment Market Value Share (%), by Drug Class, 2025 & 2034

Figure 3: Global Psoriasis Treatment Market Value Share (%), by Type, 2025 & 2034

Figure 4: Global Psoriasis Treatment Market Value Share (%), by Product Type, 2025 & 2034

Figure 5: Global Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 6: Global Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 7: Global Psoriasis Treatment Market Value (USD billion), by Region, 2025 & 2034

Figure 8: North America Psoriasis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 9: North America Psoriasis Treatment Market Value Share (%), by Drug Class, 2025

Figure 10: North America Psoriasis Treatment Market Value (USD billion), by Type, 2025 & 2034

Figure 11: North America Psoriasis Treatment Market Value Share (%), by Type, 2025

Figure 12: North America Psoriasis Treatment Market Value (USD billion), by Product Type, 2025 & 2034

Figure 13: North America Psoriasis Treatment Market Value Share (%), by Product Type, 2025

Figure 14: North America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 15: North America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 16: North America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 17: North America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 18: North America Psoriasis Treatment Market Value (USD billion), By Country, 2025 & 2034

Figure 19: North America Psoriasis Treatment Market Value Share (%), By Country, 2025

Figure 20: Europe Psoriasis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 21: Europe Psoriasis Treatment Market Value Share (%), by Drug Class, 2025

Figure 22: Europe Psoriasis Treatment Market Value (USD billion), by Type, 2025 & 2034

Figure 23: Europe Psoriasis Treatment Market Value Share (%), by Type, 2025

Figure 24: Europe Psoriasis Treatment Market Value (USD billion), by Product Type, 2025 & 2034

Figure 25: Europe Psoriasis Treatment Market Value Share (%), by Product Type, 2025

Figure 26: Europe Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 27: Europe Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 28: Europe Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 29: Europe Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 30: Europe Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 31: Europe Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 32: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 33: Asia Pacific Psoriasis Treatment Market Value Share (%), by Drug Class, 2025

Figure 34: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Type, 2025 & 2034

Figure 35: Asia Pacific Psoriasis Treatment Market Value Share (%), by Type, 2025

Figure 36: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Product Type, 2025 & 2034

Figure 37: Asia Pacific Psoriasis Treatment Market Value Share (%), by Product Type, 2025

Figure 38: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 39: Asia Pacific Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 40: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 41: Asia Pacific Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 42: Asia Pacific Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 43: Asia Pacific Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 44: Latin America Psoriasis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 45: Latin America Psoriasis Treatment Market Value Share (%), by Drug Class, 2025

Figure 46: Latin America Psoriasis Treatment Market Value (USD billion), by Type, 2025 & 2034

Figure 47: Latin America Psoriasis Treatment Market Value Share (%), by Type, 2025

Figure 48: Latin America Psoriasis Treatment Market Value (USD billion), by Product Type, 2025 & 2034

Figure 49: Latin America Psoriasis Treatment Market Value Share (%), by Product Type, 2025

Figure 50: Latin America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 51: Latin America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 52: Latin America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 53: Latin America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 54: Latin America Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 55: Latin America Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 56: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Drug Class, 2025 & 2034

Figure 57: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Drug Class, 2025

Figure 58: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Type, 2025 & 2034

Figure 59: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Type, 2025

Figure 60: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Product Type, 2025 & 2034

Figure 61: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Product Type, 2025

Figure 62: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 63: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Route of Administration, 2025

Figure 64: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 65: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 66: Middle East & Africa Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 67: Middle East & Africa Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2025

Figure 68: Global Psoriasis Treatment Market Share (%), By Company, 2025

List of Tables

Table 1: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021–2034

Table 2: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 3: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021–2034

Table 4: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 5: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 6: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 7: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 8: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 9: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 10: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034

Table 11: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 12: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 13: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 14: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 15: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 16: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 17: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 18: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034

Table 19: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 20: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: U.K. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 22: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 23: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 24: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 25: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 26: Scandinavia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 27: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 28: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 29: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 30: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 31: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034

Table 32: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 33: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 34: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 35: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 36: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 37: Australia & New Zealand Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 38: Rest of Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 39: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 40: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 41: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 42: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034

Table 43: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 44: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 45: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 46: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 47: Rest of Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 48: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034

Table 49: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 50: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2021-2034

Table 51: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034

Table 52: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034

Table 53: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 54: GCC Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 55: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

Table 56: Rest of Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 166

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com